Kangwei Zhu

Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Individualized Prediction of Postoperative Survival in Gallbladder Cancer: A Nomogram Based on SEER Data and External Validation.

Individualized Prediction of Postoperative Survival in Gallbladder Cancer: A Nomogram Based on SEER Data and External Validation.

Journal: Cancers

Published: May 06, 2025

Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Journal: Cell death & disease

Published: April 13, 2025

PLK4 as a Key Regulator of Neuroblastoma Differentiation and a Promising Therapeutic Target.

PLK4 as a Key Regulator of Neuroblastoma Differentiation and a Promising Therapeutic Target.

Journal: International journal of biological sciences

Published: February 03, 2025

Sorafenib combined with TACE improves survival in patients with hepatocellular carcinoma with vascular invasion.

Sorafenib combined with TACE improves survival in patients with hepatocellular carcinoma with vascular invasion.

Journal: Bioscience trends

Published: October 20, 2024

Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.

Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.

Journal: Journal of hepatocellular carcinoma

Published: July 23, 2024

A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy.

A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy.

Journal: Journal of hepatocellular carcinoma

Published: November 13, 2023

Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors.

Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors.

Journal: Frontiers in genetics

Published: August 02, 2023

A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.

A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: January 25, 2023

Autophagy Inhibition Contributes to Apoptosis of PLK4 Downregulation-induced Dormant Cells in Colorectal Cancer.

Autophagy Inhibition Contributes to Apoptosis of PLK4 Downregulation-induced Dormant Cells in Colorectal Cancer.

Journal: International journal of biological sciences

Published: October 17, 2022

Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study.

Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study.

Journal: Journal of hepatocellular carcinoma

Published: May 29, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026